Douglas Broom and Madeleine North
2024年11月21日
Antimicrobial resistance (AMR), also known as antibiotic resistance, is a major health concern. It occurs when microbes, such as bacteria, viruses, and fungi, become resistant to the drugs used to treat them. This makes infections harder to treat and increases the risk of death.
AMR is a global problem, with each year superbugs causing 1.27 million deaths and contributing to almost 5 million deaths. The issue is particularly acute in low- and middle-income countries, where the overuse of antibiotics is more common.
AMR has far-reaching consequences beyond human health. It threatens food security, as we rely on antibiotics to treat sick animals and plants. AMR also poses a threat to environmental security, as antibiotics are released into the environment through human waste and industrial wastewater.
The pipeline of new antibiotics is almost empty, and there is a lack of incentives for companies to invest in developing new ones. This is due to a market failure, where the true value of antibiotics is not reflected in their price.
Governments and industry can play a big role in addressing this issue. They need to work together to find solutions to the market failure and promote the responsible use of antibiotics. By taking these steps, we can mitigate AMR and save lives.